HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Methyl iodide → (R)-tert-butyl 4-((3-carbamoyl-6-(5-(methylthio)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-3,3-dimethylpiperidine-1-carboxylate

HRID 877747
Notes
Print preview

Reaction equation

HRID 877747 reaction equation
[C:1]([C:4]1[CH:9]=[N:8][N:7]2[CH:10]=[C:11]([C:13]([NH:15][NH2:16])=[O:14])[CH:12]=[C:6]2[C:5]=1[NH:17][C@@H:18]1[CH2:23][CH2:22][N:21]([C:24]([O:26][C:27]([CH3:30])([CH3:29])[CH3:28])=[O:25])[CH2:20][C:19]1([CH3:32])[CH3:31])(=[O:3])[NH2:2].N1([C:38](N2C=CN=C2)=[S:39])C=CN=C1.[CH2:45](N(CC)CC)C.IC>O1CCCC1>[C:1]([C:4]1[CH:9]=[N:8][N:7]2[CH:10]=[C:11]([C:13]3[O:14][C:45]([S:39][CH3:38])=[N:16][N:15]=3)[CH:12]=[C:6]2[C:5]=1[NH:17][C@@H:18]1[CH2:23][CH2:22][N:21]([C:24]([O:26][C:27]([CH3:30])([CH3:29])[CH3:28])=[O:25])[CH2:20][C:19]1([CH3:32])[CH3:31])(=[O:3])[NH2:2]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

6

Reactant 4

HCID 6328Methyl iodideHCID 8471TriethylamineHCID 802641,1'-ThiocarbonyldiimidazoleHCID 68291130(R)-tert-butyl 4-((3-carbamoyl-6-(hydrazinecarbonyl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-3,3-dimethylpiperidine-1-carboxylate

Product 1

HCID 68350378(R)-tert-butyl 4-((3-carbamoyl-6-(5-(methylthio)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-3,3-dimethylpiperidine-1-carboxylate
Yield 94.4%

Reagents, catalysts & solvents 1

HCID 8028TetrahydrofuranSolvent

Procedure

A solution of (R)-tert-butyl 4-((3-carbamoyl-6-(hydrazinecarbonyl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-3,3-dimethylpiperidine-1-carboxylate (380 mg, 0.853 mmol) and di(1H-imidazol-1-yl)methanethione (175 mg, 0.981 mmol) in tetrahydrofuran (10 mL) was stirred at room temperature for 10 min then heated to reflux for 100 min. After cooling to room temperature, triethylamine (0.357 mL, 2.56 mmol) and iodomethane (0.107 mL, 1.706 mmol) were added. The resulting mixture was stirred at room temperature for 5 h. The tetrahydrofuran solvent was evaporated in vacuo. The residue was triturated with water. The solid product was collected by filtration to give (R)-tert-butyl 4-((3-carbamoyl-6-(5-(methylthio)-1,3,4-oxadiazol-2-yl)pyrrolo[1,2-b]pyridazin-4-yl)amino)-3,3-dimethylpiperidine-1-carboxylate as white solid (0.404 g, 94% yield). 1H NMR (400 MHz, chloroform-d) δ ppm 10.78 (d, J=8.4 Hz, 1H), 8.10 (d, J=1.8 Hz, 1H), 7.94 (s, 1H), 5.50 (br. s., 2H), 4.01 (dd, J=9.4, 5.8 Hz, 2H), 3.72 (br. s., 1H), 3.18 (br. s., 1H), 2.91 (br. s., 1H), 2.80 (s, 3H), 2.06 (d, J=14.3 Hz, 1H), 1.89-1.75 (m, 1H), 1.49 (s, 9H), 1.12 (s, 3H), 1.05 (s, 3H); MS (ES+) m/z: 502.3 (M+H); LC retention time: 4.241 min (analytical HPLC Method H).

Workup

  1. temperaturethen heated
  2. temperatureto reflux for 100 min
  3. customThe tetrahydrofuran solvent was evaporated in vacuo
  4. customThe residue was triturated with water
  5. filtrationThe solid product was collected by filtration

Sources & evidence

ORD record
ord-d0e01d80e9544b11ae645ae579867b4d
Source dataset
uspto-grants-2015_03
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08987268B2

Reaction notes

Loading…

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes